Vardenafil treatment for erectile dysfunction (Q35638042)

9 August 2017

1 reference

title

Vardenafil treatment for erectile dysfunction (English)

1 reference

9 August 2017

Susan M Crowe

1

1 reference

9 August 2017

Daniel S Streetman

series ordinal

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Annals of Pharmacotherapy

9 August 2017

published in

1 reference

9 August 2017

volume

38

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

77-85

1 reference

Community-based study of erectile dysfunction and sildenafil use: the Rancho Bernardo study

9 August 2017

cites work

1 reference

21 January 2018

1 reference

Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort

21 January 2018

1 reference

Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction

21 January 2018

1 reference

Medical treatment of erectile dysfunction

21 January 2018

1 reference

Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.

21 January 2018

1 reference

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

21 January 2018

1 reference

A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection

21 January 2018

1 reference

Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study

21 January 2018

1 reference

Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose

21 January 2018

1 reference

Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction

21 January 2018

1 reference

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

21 January 2018

1 reference

Oral drug therapy for erectile dysfunction

21 January 2018

1 reference

The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.

21 January 2018

1 reference

Onset and duration of action of sildenafil for the treatment of erectile dysfunction

21 January 2018

1 reference

Sildenafil for male erectile dysfunction: a systematic review and meta-analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D019

1 reference

9 August 2017

1 reference